InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001415889-24-026617 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-12 2024-11-07 KNSA Levy Richard S Dir M - OptEx — +1,303 14.2K +10% —
D 2024-11-12 2024-11-07 KNSA Levy Richard S Dir M - OptEx $0.00 -1,303 0 -100% $0
D 2024-11-12 2024-11-07 KNSA Levy Richard S Dir A - Grant $0.00 +1,303 1,303 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Share 2024-11-07 M A 1,303 — 14,200 D — — (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
2 Derivative Restricted Share Units 2024-11-07 M D 1,303 $0.00 0 D — · — to — 1,303 Class A Ordinary Shares (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs.
3 Derivative Restricted Share Units 2024-11-07 A A 1,303 $0.00 1,303 D — · — to — 1,303 Class A Ordinary Shares (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F2) The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs.